We found that COVID-19 patients with the 4G4G genotype had high PAI-1 transcript levels in PBMCs and low circulating plasmin and IL-1β or proTGFβ levels, indicating a mild inflammatory response. The gene discussed is PLG; the disease is COVID-19.